Circulatory miRNAs as Correlates of Elevated Intra-Pancreatic Fat Deposition in a Mixed Ethnic Female Cohort: The TOFI_Asia Study
暂无分享,去创建一个
R. D’Souza | F. Ramzan | Ivana R Sequeira-Bisson | Louise W. Lu | Cameron J. Mitchell | Mark H. Vickers | Sally D. Poppitt | David Cameron-Smith
[1] C. Luchini,et al. Pancreatic steatosis and metabolic pancreatic disease: a new entity? , 2023, Internal and Emergency Medicine.
[2] E. Golemis,et al. Intrapancreatic fat, pancreatitis, and pancreatic cancer , 2023, Cellular and Molecular Life Sciences.
[3] Sneha S. Pillai,et al. Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression , 2023, Biomedicines.
[4] C. Bian,et al. Identification of key microRNAs in exosomes derived from patients with the severe acute pancreatitis. , 2022, Asian Journal of Surgery.
[5] J. Ampuero,et al. Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver , 2022, Frontiers in Endocrinology.
[6] K. Hollingsworth,et al. Pancreas Fat, an Early Marker of Metabolic Risk? A Magnetic Resonance Study of Chinese and Caucasian Women: TOFI_Asia Study , 2022, Frontiers in Physiology.
[7] Juyeon Ko,et al. Associations between Intra-Pancreatic Fat Deposition, Pancreas Size, and Pancreatic Enzymes in Health and after an Attack of Acute Pancreatitis , 2021, Obesity Facts.
[8] K. Fraser,et al. Untargeted metabolomics reveals plasma metabolites predictive of ectopic fat in pancreas and liver as assessed by magnetic resonance imaging: the TOFI_Asia study , 2021, International Journal of Obesity.
[9] Yannan Jiang,et al. Visceral Adiposity and Glucoregulatory Peptides are Associated with Susceptibility to Type 2 Diabetes: The TOFI_Asia Study , 2020, Obesity.
[10] C. Valério,et al. NAFLD as a continuum: from obesity to metabolic syndrome and diabetes , 2020, Diabetology & Metabolic Syndrome.
[11] Hongliang Li,et al. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases , 2020, Circulation research.
[12] F. Hu,et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. , 2019, The lancet. Diabetes & endocrinology.
[13] J. Markworth,et al. Circulatory miRNA biomarkers of metabolic syndrome , 2019, Acta Diabetologica.
[14] Tao Wang,et al. MiR-21-3p aggravates injury in rats with acute hemorrhagic necrotizing pancreatitis by activating TRP signaling pathway. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[15] Liangping Li,et al. Down‐regulation of microRNA‐375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non‐alcoholic fatty liver disease , 2018, Clinical and experimental pharmacology & physiology.
[16] G. Al-Kafaji,et al. Evaluation of Two-Diabetes Related microRNAs Suitability as Earlier Blood Biomarkers for Detecting Prediabetes and type 2 Diabetes Mellitus , 2018, Journal of clinical medicine.
[17] M. Puzianowska-Kuźnicka,et al. NGS Reveals Molecular Pathways Affected by Obesity and Weight Loss-Related Changes in miRNA Levels in Adipose Tissue , 2017, International journal of molecular sciences.
[18] S. Poppitt,et al. Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta‐analysis , 2017, Diabetes/metabolism research and reviews.
[19] L. Bouwens,et al. Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds , 2017, PloS one.
[20] J. Markworth,et al. Acute resistance exercise modulates microRNA expression profiles: Combined tissue and circulatory targeted analyses , 2017, PloS one.
[21] M. Stoffel,et al. MicroRNAs as stress regulators in pancreatic beta cells and diabetes , 2017, Molecular metabolism.
[22] A. Peters,et al. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease , 2017, PloS one.
[23] Ke Li,et al. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation , 2017, Scientific Reports.
[24] Roy Taylor,et al. Quantification of intrapancreatic fat in type 2 diabetes by MRI , 2017, PloS one.
[25] L. Plank,et al. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression. , 2017, Metabolism: clinical and experimental.
[26] Z. Liao,et al. Novel blood-based microRNA biomarker panel for early diagnosis of chronic pancreatitis , 2017, Scientific Reports.
[27] R. Catanzaro,et al. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease , 2016, World journal of gastroenterology.
[28] Z. Younossi,et al. Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease , 2016, BMJ open gastroenterology.
[29] Yan-ji Luo,et al. Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes , 2016, Medicine.
[30] M. Foti,et al. Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption , 2016, Gut.
[31] H. Yki-Järvinen,et al. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD—A Systematic Review , 2016, International journal of molecular sciences.
[32] D. Marsh,et al. Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs , 2016, PloS one.
[33] R. Vyzula,et al. MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma , 2015, Diagnostic Pathology.
[34] Sha Li,et al. Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function , 2015, Genom. Proteom. Bioinform..
[35] P. Linsley,et al. Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver. , 2012, RNA.
[36] E. Gamazon,et al. Population differences in microRNA expression and biological implications , 2011, RNA biology.
[37] J. Timmons,et al. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity , 2011, BMC endocrine disorders.
[38] Jaimie N. Davis,et al. Ethnic Differences in Pancreatic Fat Accumulation and Its Relationship With Other Fat Depots and Inflammatory Markers , 2011, Diabetes Care.
[39] F. Lynn,et al. Meta-regulation: microRNA regulation of glucose and lipid metabolism , 2009, Trends in Endocrinology & Metabolism.
[40] Qin-Hui Tuo,et al. CHANGES IN microRNA (miR) PROFILE AND EFFECTS OF miR‐320 IN INSULIN‐RESISTANT 3T3‐L1 ADIPOCYTES , 2009, Clinical and experimental pharmacology & physiology.
[41] Charles E. Vejnar,et al. Integration of microRNA miR-122 in hepatic circadian gene expression. , 2009, Genes & development.
[42] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[43] H. Pitt,et al. Nonalcoholic fatty pancreas disease. , 2007, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[44] R. Unger. Lipid overload and overflow: metabolic trauma and the metabolic syndrome , 2003, Trends in Endocrinology & Metabolism.
[45] D. Dreiling,et al. Effects of sex and age on pancreatic secretion , 1986, International journal of pancreatology : official journal of the International Association of Pancreatology.
[46] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[47] D. Gauguier,et al. Biological roles of microRNAs in the control of insulin secretion and action. , 2017, Physiological genomics.